GeneDx Holdings Corp. (WGS)
$68.61+5.62%Close
SELLCRISIS · day 16
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV45.6%–201.3%
- Market cap
- $2.0B
- Beta
- 1.97
- P/E (TTM)
- -18.85
- IV-%ile
- 79
- IV ATM
- 92.9%
- Short % float
- 20.53%
- Days to cover
- 6.0
- SI change
- -4.4%
- 1W
- +0.12%
- 1M
- -27.50%
- vs SPY 1W
- +1.10%
- vs SPY 1M
- -29.37%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on WGS?
- LOPJLB’s latest quantitative signal on GeneDx Holdings Corp. (WGS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is WGS in?
- GeneDx Holdings Corp. (WGS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does GeneDx Holdings Corp. (WGS) do?
- GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and c…